Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Diagnostic accuracy and quality of management in anaphylactic shock is assessed in three conditions: expected, unexpected with no distractor, unexpected with distractor
participants: physicians taking part in voluntary workshops. Participants are allocated to teams of three design: prospective, randomized, single-blind setting: simulated anaphylactic shock intervention: participants are allocated to 3 versions of the scenario: 1) expected, 2) unexpected but no distractor, 3) unexpected with distractor
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Expected | Active Comparator | Anaphylactic shock occurs after the injection of a drug known to cause allergic reactions |
|
| Unexpected, no distractor | Active Comparator | Anaphylactic shock occurs unexpectedly, but their is no medical distractor |
|
| Unexpected, with distractor | Active Comparator | Anaphylactic shock occurs unexpectedly. Scenario is set up such, that a tension pneumothorax may be a likely explanation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Diagnostic context | Other | A life-threatening situation occurs in 3 different contexts |
|
| Measure | Description | Time Frame |
|---|---|---|
| Correct diagnosis of anaphylactic shock | Diagnosis of anaphylactic shock is explicitly stated by at least one team member within a time frame of 15 minutes after onset | 15 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment of anaphylactic shock with epinephrine ≥ 0.3mg intravenously | Anaphylactic shock is correctly treated with epinephrine in an appropriate dose (≥ 0.3mg intravenously) within a time frame of 5 minutes after diagnosis | 5 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephan Marsch | University Hospital, Basel, Switzerland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital | Basel | Canton of Basel-City | 4031 | Switzerland |
Secondary data can be shared Videorecordings are strictly confidential and cannot be shared
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided